Cargando…

AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients

Due to an aging population, assisted-care options are required so that senior citizens may maintain their independence at home for a longer time and rely less on caretakers. Ambient Assisted Living (AAL) encourages the creation of solutions that can help to optimize the environment for senior citize...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Shakeel, Naga Srinivasu, Parvathaneni, Alhumam, Abdulaziz, Alarfaj, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689636/
https://www.ncbi.nlm.nih.gov/pubmed/36359582
http://dx.doi.org/10.3390/diagnostics12112739
_version_ 1784836585333719040
author Ahmed, Shakeel
Naga Srinivasu, Parvathaneni
Alhumam, Abdulaziz
Alarfaj, Mohammed
author_facet Ahmed, Shakeel
Naga Srinivasu, Parvathaneni
Alhumam, Abdulaziz
Alarfaj, Mohammed
author_sort Ahmed, Shakeel
collection PubMed
description Due to an aging population, assisted-care options are required so that senior citizens may maintain their independence at home for a longer time and rely less on caretakers. Ambient Assisted Living (AAL) encourages the creation of solutions that can help to optimize the environment for senior citizens with assistance while greatly reducing their challenges. A framework based on the Internet of Medical Things (IoMT) is used in the current study for the implementation of AAL technology to help patients with Type-2 diabetes. A glucose oxide sensor is used to monitor diabetic elderly people continuously. Spectrogram images are created from the recorded data from the sensor to assess and detect aberrant glucose levels. DenseNet-169 examines and analyzes the spectrogram pictures, and messages are sent to caregivers when aberrant glucose levels are detected. The current work describes both the spectrogram image analysis and the signal-to-spectrogram generating method. The study presents a future perspective model for a mobile application for real-time patient monitoring. Benchmark metrics evaluate the application’s performances, including sensitivity, specificity, accuracy, and F1-score. Several cross--validations are used to evaluate the model’s performance. The findings demonstrate that the proposed model can correctly identify patients with abnormal blood glucose levels.
format Online
Article
Text
id pubmed-9689636
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96896362022-11-25 AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients Ahmed, Shakeel Naga Srinivasu, Parvathaneni Alhumam, Abdulaziz Alarfaj, Mohammed Diagnostics (Basel) Article Due to an aging population, assisted-care options are required so that senior citizens may maintain their independence at home for a longer time and rely less on caretakers. Ambient Assisted Living (AAL) encourages the creation of solutions that can help to optimize the environment for senior citizens with assistance while greatly reducing their challenges. A framework based on the Internet of Medical Things (IoMT) is used in the current study for the implementation of AAL technology to help patients with Type-2 diabetes. A glucose oxide sensor is used to monitor diabetic elderly people continuously. Spectrogram images are created from the recorded data from the sensor to assess and detect aberrant glucose levels. DenseNet-169 examines and analyzes the spectrogram pictures, and messages are sent to caregivers when aberrant glucose levels are detected. The current work describes both the spectrogram image analysis and the signal-to-spectrogram generating method. The study presents a future perspective model for a mobile application for real-time patient monitoring. Benchmark metrics evaluate the application’s performances, including sensitivity, specificity, accuracy, and F1-score. Several cross--validations are used to evaluate the model’s performance. The findings demonstrate that the proposed model can correctly identify patients with abnormal blood glucose levels. MDPI 2022-11-09 /pmc/articles/PMC9689636/ /pubmed/36359582 http://dx.doi.org/10.3390/diagnostics12112739 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ahmed, Shakeel
Naga Srinivasu, Parvathaneni
Alhumam, Abdulaziz
Alarfaj, Mohammed
AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients
title AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients
title_full AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients
title_fullStr AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients
title_full_unstemmed AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients
title_short AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients
title_sort aal and internet of medical things for monitoring type-2 diabetic patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689636/
https://www.ncbi.nlm.nih.gov/pubmed/36359582
http://dx.doi.org/10.3390/diagnostics12112739
work_keys_str_mv AT ahmedshakeel aalandinternetofmedicalthingsformonitoringtype2diabeticpatients
AT nagasrinivasuparvathaneni aalandinternetofmedicalthingsformonitoringtype2diabeticpatients
AT alhumamabdulaziz aalandinternetofmedicalthingsformonitoringtype2diabeticpatients
AT alarfajmohammed aalandinternetofmedicalthingsformonitoringtype2diabeticpatients